Pharmalucence and Bosch Packaging Technology are hosting "Innovation Symposium 2013 on Injectable Drug Manufacturing" March 11-13 at the Burlington Marriott Hotel in Burlington, MA. Developed to address the needs of pharmaceutical manufacturing professionals, the symposium will provide the latest industry information and case studies on injectable pharmaceuticals.
Joining Pharmalucence and Bosch Packaging Technology are IMA Life North America, Millipore, Sartorius, and IPS.
The agenda includes the following:
Speakers and exhibitors at Pharmapack Europe February 15-16 will be focusing on easing drug delivery while overcoming industry’s challenges.
Can’t Make It to Europe?
Building on a long history of reconstitution, two companies devise a new system for sterile water for injection intended to promote ease of use and dosing.
By Mike Schaefers, West Pharmaceutical Services; and Thomas Otto, Vetter
The process of freeze-drying injectable drugs by removing water from the material and sealing the material in a vial, known as lyophilization, was developed in the mid 1930s. Since then, lyophilization has created a faster and more convenient path for many new drugs, including biologics, to reach the market.
JHP Pharmaceuticals announced that Stuart Hinchen would succeed Peter Jenkins as Chief Executive Officer of the company effective July 1, 2011.
Vetter has installed three additional state-of-the-art lyophilizers at the company’s Ravensburg, Germany Vetter South facility, nearly doubling its number of freeze-dryers. Altogether, the site will be able to produce up to 24 million lyophilized units annually, the company said in a press release.
The new equipment increases the number of lyophilizers across all Vetter facilities by 30 percent.